Peer Review reports
From: USP54 is a potential therapeutic target in castration-resistant prostate cancer
| Original Submission | ||
|---|---|---|
| 20 Nov 2023 | Submitted | Original manuscript |
| 1 Dec 2023 | Author responded | Author comments - Jun Zhang |
| 4 Dec 2023 | Author responded | Author comments - Jun Zhang |
| Resubmission - Version 2 | ||
| 1 Dec 2023 | Submitted | Manuscript version 2 |
| 4 Dec 2023 | Reviewed | Reviewer Report |
| 8 Dec 2023 | Reviewed | Reviewer Report |
| 11 Dec 2023 | Reviewed | Reviewer Report |
| 13 Dec 2023 | Reviewed | Reviewer Report - Thanigaivelan Kanagasabai |
| 27 Dec 2023 | Author responded | Author comments - Jun Zhang |
| Resubmission - Version 3 | ||
| 27 Dec 2023 | Submitted | Manuscript version 3 |
| 28 Dec 2023 | Author responded | Author comments - Jun Zhang |
| Resubmission - Version 4 | ||
| 28 Dec 2023 | Submitted | Manuscript version 4 |
| 29 Dec 2023 | Reviewed | Reviewer Report |
| 29 Dec 2023 | Reviewed | Reviewer Report |
| 4 Jan 2024 | Reviewed | Reviewer Report |
| 19 Jan 2024 | Reviewed | Reviewer Report |
| 24 Jan 2024 | Author responded | Author comments - Jun Zhang |
| Resubmission - Version 5 | ||
| 24 Jan 2024 | Submitted | Manuscript version 5 |
| 25 Jan 2024 | Author responded | Author comments - Jun Zhang |
| Resubmission - Version 6 | ||
| 25 Jan 2024 | Submitted | Manuscript version 6 |
| Publishing | ||
| 25 Jan 2024 | Editorially accepted | |
| 6 Feb 2024 | Article published | 10.1186/s12894-024-01418-7 |
You can find further information about peer review here.